Question explored with the scientific record
Is ivermectin best administered to humans using tablets
The short version: oral ivermectin tablets are the standard, well-studied route for parasitic infections, but the evidence for COVID-19 is weak and the safety data is thin for off-label use.
The evidence you retrieved is almost entirely about oral ivermectin tablets for parasitic diseases like scabies, strongyloidiasis, and filariasis. For those conditions, the tablet is the established route. Studies show it works: a single oral dose of 200 µg/kg cured about 76% of strongyloidiasis cases compared to 38% for albendazole [25], and it outperformed topical malathion for head lice, with 95% of patients lice-free at day 15 versus 85% [9]. The pharmacokinetic data from 2003 and 2006 [1, 4] shows the oral route produces measurable blood levels, and the 2015 scabies trial found oral and topical ivermectin had similar cure rates after two weeks [8]. For these parasitic infections, the tablet is the best-studied and most practical route.
For COVID-19, the picture is different. A 2025 meta-analysis of 23 randomized trials with over 12,000 patients found no statistically significant improvement in viral clearance, hospitalization duration, or symptom resolution with ivermectin [24]. A pharmacokinetic modeling study from 2020 calculated that the standard oral dose of 200 µg/kg produces lung concentrations only about one-fifth of the level needed to inhibit SARS-CoV-2 in the lab [37]. The evidence for COVID-19 does not support the oral tablet as effective.
Safety is the other concern. A 2023 case report documented a 70-year-old woman who developed drug-induced liver injury after taking oral ivermectin 12 mg daily for COVID-19 prophylaxis, with a RUCAM score of 8 indicating a highly probable association [14]. A 2009 study found ivermectin inhibits several mammalian P-type ATPases at concentrations in the low micromolar range, including the sodium-potassium pump and SERCA, which is a mechanism for potential toxicity at higher doses [19]. The safety data for long-term or high-dose oral use is not robust.
| Condition | Oral ivermectin efficacy | Comparator efficacy | Notes |
|---|---|---|---|
| Strongyloidiasis | 76% cure rate [25] | 38% (albendazole) [25] | Single 200 µg/kg dose |
| Head lice | 95% lice-free at day 15 [9] | 85% (malathion lotion) [9] | Two doses, 7 days apart |
| Scabies | 87.5% cure at 4 weeks [17] | 62.5% (crotamiton cream) [17] | Retreatment at 2 weeks |
| COVID-19 | No significant benefit [24] | Placebo [24] | Meta-analysis of 23 trials |
My call: for parasitic infections, oral ivermectin tablets are the best-studied route and work well. For COVID-19, the evidence does not support their use, and the safety data for off-label high-dose regimens is concerning. Confidence: high for parasitic infections, moderate for COVID-19.
Sources used 39
-
Robotic Sample Preparation and HPLC Determination of the Major Component of Ivermectin in Human Plasma
Develops and validates a robotic, automated sample preparation workflow for quantifying the major ivermectin component I-B1a in human plasma by HPLC with fluorescence detection, and demonstrates high-throughput analysis across >1200 clinical samples and pharmacokinetic data in 1…
DOI: 10.1081/JLC-120018891 -
Efficacy and tolerance of oral ivermectin in scabies
This open-label study investigates the efficacy and tolerance of oral ivermectin in treating scabies, demonstrating high therapeutic efficacy and good tolerance among patients.
DOI: 10.1016/s0926-9959(98)00075-0 -
The effect of ivermectin® on fertility, fecundity and mortality of Anopheles arabiensis fed on treated men in Ethiopia
A randomized, blinded study in Ethiopia evaluating whether a single oral dose of ivermectin given to six healthy male volunteers can affect mortality, fecundity, and fertility of Anopheles arabiensis mosquitoes that feed on treated humans, finding early increases in mosquito mor…
DOI: 10.1186/s12936-019-2988-3 -
Liquid chromatographic assay of ivermectin in human plasma for application to clinical pharmacokinetic studies
This study presents a sensitive and selective high-performance liquid chromatography (HPLC) method for quantifying ivermectin in human plasma, which effectively separates the drug from its metabolites and demonstrates high accuracy and precision for clinical pharmacokinetic stud…
DOI: 10.1016/j.jpba.2005.08.026 -
Oral Ivermectin Treatment in Two Cases Of Scabies: Effective in Crusted Scabies Induced by Corticosteroid but Ineffective in Nail Scabies
This study reports two cases of scabies treated with oral ivermectin, demonstrating its effectiveness in crusted scabies induced by corticosteroids while highlighting its ineffectiveness in treating nail scabies.
DOI: 10.1111/j.1346-8138.2003.tb00408.x -
Effectiveness of Oral Ivermectin Treatment in Cases Unresponsive to Classical Demodex Blepharitis Treatment
This study evaluated oral ivermectin (0.2 mg/kg, two doses 30 days apart) in 35 patients with Demodex blepharitis unresponsive to classical treatment, finding marked improvement in ocular symptoms (OSDI) and parasite load, suggesting efficacy but warranting randomized trials.
DOI: 10.4274/tpd.galenos.2025.39260 -
The effect of oral anthelmintics on the survivorship and re-feeding frequency of anthropophilic mosquito disease vectors
This laboratory study tests whether human mass drug administration with ivermectin, relative to other standard anthelmintics, can reduce survival and alter re-feeding behavior of anthropophilic mosquito vectors (Anopheles gambiae s.s. and Aedes aegypti) by exposing laboratory-ra…
DOI: 10.1016/j.actatropica.2010.06.001 -
Clinical efficacy and safety of topical versus oral ivermectin in treatment of uncomplicated scabies
This study compares the efficacy and safety of topical versus oral ivermectin in treating uncomplicated scabies, finding both treatments to be equally effective and safe, with a high cure rate after one week.
DOI: 10.1111/dth.12310 -
Oral Ivermectin versus Malathion Lotion for Difficult-to-Treat Head Lice
This study demonstrates that oral ivermectin is significantly more effective than topical malathion lotion in treating difficult-to-treat head lice infestations in children, with a higher rate of lice-free patients observed after treatment.
DOI: 10.1056/NEJMoa0905471 -
Strongyloides stercoralis infestation in a pediatric patient
A pediatric patient from Ecuador with fever, abdominal pain, diarrhea, and eosinophilia had Strongyloides stercoralis larvae detected in stool and recovered after ivermectin therapy, illustrating diagnostic challenges of parasitic infections in non-endemic settings.
DOI: 10.21931/rb/2021.06.03.27 -
Comparative Study of Efficacy of Oral Ivermectin Versus Some Topical Antiscabies Drugs in the Treatment of Scabies
This study evaluates the efficacy and safety of oral Ivermectin compared to topical treatments such as Permethrin, Gamma benzene hexachloride, and benzyl benzoate for managing scabies, highlighting the need for effective community treatment options.
DOI: 10.7860/jcdr/2014/9092.4878 -
COVID-19 and a Tale of Three Drugs: To Repurpose, or Not to Repurpose–That Was the Question
This article critically reviews COVID-19 drug repurposing with a focus on hydroxychloroquine, ivermectin, and remdesivir, outlining the evidence, controversies, regulatory responses, and ongoing debates about their efficacy, safety, and scientific integrity.
DOI: 10.3390/v17070881 -
Guideline for the diagnosis and treatment of scabies in Japan (third edition)
This third-edition clinical guideline from the Japanese Dermatological Association recommends phenothrin lotion or oral ivermectin as first-line therapy for common scabies, classifies scabies into common and crusted types based on mite count, and specifies that definitive diagno…
DOI: 10.1111/1346-8138.13896 -
Ivermectin drug induced liver injury
A 70-year-old woman developed jaundice and cholestatic hepatitis 3 weeks after starting oral ivermectin 12 mg daily for COVID-19 prophylaxis; liver biopsy showed DILI pattern, RUCAM score 8, and prednisone normalized liver enzymes within 3 months.
DOI: 10.7196/samj.2023.v113i6.624 -
Effectiveness of Oral Ivermectin and Malathion Lotion for Difficult-to-Treat Head Lice
This study compares the efficacy of oral ivermectin and topical malathion lotion for treating difficult-to-treat head lice infestations, finding that ivermectin is significantly more effective.
DOI: 10.1001/archdermatol.2010.400 -
Orange juice decreases the oral bioavailability of ivermectin in healthy volunteers
This study investigates the effect of Ginkgo biloba extract (EGb761) on the pharmacokinetics of omeprazole, revealing significant interactions that suggest both hepatic induction and renal inhibition of drug metabolism.
DOI: 10.1016/s0009-9236(03)90702-8 -
Comparison of oral ivermectin versus crotamiton 10% cream in the treatment of scabies
In this randomized Iranian trial, a single oral dose of ivermectin was compared with crotamiton 10% cream for scabies; ivermectin showed higher cure rates at four weeks after retreatment and was similar at two weeks, with acceptable safety, suggesting ivermectin's superiority fo…
DOI: 10.3109/15569527.2013.768258 -
Efficacy of injectable versus topical formulation of ivermectin against Anopheles stephensi mosquitoes feeding on different body locations of treated Holstein calves
This study compared the mosquitocidal efficacy of injectable versus topical (pour-on) ivermectin against Anopheles stephensi fed on different body locations of treated Holstein calves, finding both formulations reduced survival and fecundity for up to 9 and 14 days, with topical…
DOI: 10.1186/s13071-025-07225-9 -
Ivermectin is a nonselective inhibitor of mammalian P-type ATPases
This study investigates the nonselective inhibitory effects of ivermectin on mammalian P-type ATPases, including SERCA, Na+/K+-ATPase, and H+/K+-ATPase, highlighting potential adverse effects at higher doses.
DOI: 10.1007/s00210-009-0483-z -
Imported loiasis in Italy: An analysis of 100 cases
A 20-year retrospective analysis of 100 imported loiasis cases seen at a center in Italy, detailing clinical presentations, laboratory findings, exposure origins (endemic vs non-endemic), and treatment regimens (diethylcarbamazine, ivermectin, and albendazole) with associated ad…
DOI: 10.1016/j.tmaid.2014.07.004 -
Efficacy, Safety, and Pharmacokinetics of Coadministered Diethylcarbamazine, Albendazole, and Ivermectin for Treatment of Bancroftian Filariasis
A single-dose triple-drug regimen (diethylcarbamazine, albendazole, and ivermectin) rapidly clears Wuchereria bancrofti microfilariae and yields sustained amicrofilaremia up to 2 years in Bancroftian filariasis, with more adverse events than DEC+ALB but no serious safety concern…
DOI: meta/10.1093/cid/civ882 -
Prolonged clearance of microfilaraemia in patients with bancroftian filariasis after multiple high doses of ivermectin or diethylcarbamazine
A double-blind randomized trial in Sri Lanka comparing prolonged high-dose ivermectin versus high-dose diethylcarbamazine (plus a low-dose ivermectin control) showed both regimens significantly reduced microfilaraemia and antigen levels but neither achieved complete parasite cur…
DOI: 10.1016/s0035-9203(96)90437-x -
Efficacy of Novel Formulations of Ivermectin and Albendazole in Parasitic Infections of Sheep in the Altai Mountains of Russia
The study develops mechanochemically prepared solid dispersions of ivermectin and albendazole with arabinogalactan that increase water solubility and achieve high parasiticidal efficacy against gastrointestinal nematodes, Moniezia expansa, and Melophagus ovinus in sheep at doses…
DOI: 10.18502/ijpa.v16i2.6268 -
Repurposing Anthelmintic Drugs for COVID-19 Treatment: A Comprehensive Meta-Analysis of Randomized Clinical Trials on Ivermectin and Mebendazole
An up-to-date meta-analysis of 23 randomized trials (n = 12,345) evaluating ivermectin and mebendazole for COVID-19 found no statistically significant improvement in viral clearance, hospitalization duration, or symptom resolution overall, although some individual studies sugges…
DOI: 10.3390/antibiotics14050459 -
Efficacy and safety of a single-dose veterinary preparation of ivermectin versus 7-day high-dose albendazole for chronic strongyloidiasis
This study compares the efficacy and safety of a single-dose veterinary preparation of ivermectin to a 7-day high-dose regimen of albendazole in treating chronic strongyloidiasis in Thai patients, finding that ivermectin is significantly more effective.
DOI: 10.1016/j.ijantimicag.2007.08.014 -
Safety, efficacy, and tissues residues of ivermectin in reindeer
Ivermectin given to reindeer at 5–10 times the standard dose is safe and highly effective against warble larvae, with rapid depletion of tissue residues and a 56-day meat withholding period established by FDA guidance.
DOI: 10.7557/2.10.2.794 -
Control of bancroftian filariasis in an endemic area of Polynesia by ivermectin 400 μg/kg
A field trial in Opoa, French Polynesia, shows that semi-annual mass treatment with ivermectin at 400 μg/kg over three rounds markedly reduces bancroftian filariasis prevalence (from 21% to 7%) and microfilariae levels (GMM down to 0.5% of baseline), with high safety and complia…
DOI: 10.1016/s0035-9203(96)90439-3 -
Ivermectin vs moxidectin for treating Strongyloides stercoralis infection: a systematic review
A systematic review of two randomized controlled trials (821 participants) comparing moxidectin to ivermectin for Strongyloides stercoralis infection found that moxidectin is non-inferior and as safe as ivermectin in immunocompetent adults, based on short-term outcomes from Sout…
DOI: 10.1017/s0031182024001215 -
Oral myiasis treated with ivermectin: case report
This case report describes the successful treatment of a 20-year-old female patient with oral myiasis caused by Cochliomyia hominivorax larvae using ivermectin, highlighting its efficacy as an alternative to conventional mechanical removal methods.
DOI: 10.1590/s0103-64402004000100015 -
COMPARATIVE EFFICACY OF ORAL FORMULATIONS OF IVERMECTIN AND LEVAMISOLE UNDER IN VITRO CONDITIONS AGAINST HAEMONCHUS CONTORTUS
This study compared the in vitro efficacy of oral ivermectin and levamisole against Haemonchus contortus isolated from sheep and goats, using egg hatch, larval development, and adult motility tests, found no ovicidal activity, higher larval/adult efficacy for ivermectin, and evi…
DOI: 10.57041/pjs.v72i1.290 -
Strongyloides disseminated infection successfully treated with parenteral ivermectin: case report with drug concentration measurements and review of the literature
Subcutaneous veterinary ivermectin resolved disseminated Strongyloides infection in a kidney transplant recipient when oral therapy was not possible, with pharmacokinetic data showing trough serum concentrations during therapy and accumulation after discontinuation, plus a liter…
DOI: 10.1016/j.ijantimicag.2013.07.015 -
Comparative effects of abamectin and two formulations of ivermectin on the survival of larvae of a dung‐breeding fly
This study compares the survival of larvae of the dung-breeding fly Musca vetustissima in cattle faeces treated with injectable abamectin and oral or injectable formulations of ivermectin, revealing that the oral formulation of ivermectin is eliminated more rapidly and is less h…
DOI: 10.1111/j.1751-0813.1998.tb10158.x -
Comparison of the pharmacokinetics of moxidectin and ivermectin after oral administration to beagle dogs
This study compares the pharmacokinetics of moxidectin and ivermectin in beagle dogs infected with Brugia pahangi, revealing that moxidectin has a significantly longer elimination half-life and higher peak plasma concentrations than ivermectin.
DOI: 10.1002/bdd.572 -
Oral ivermectin as an unexpected initiator of CreT2-mediated deletion in T cells
This study reveals that oral treatment with ivermectin unexpectedly activates a tamoxifen-regulated Cre recombinase fusion protein in laboratory mice, leading to unintended genetic modifications in offspring.
DOI: 10.1038/ni.2232 -
Relative bioavailability and comparative clinical efficacy of different ivermectin oral formulations in lambs
This Uruguayan study compared three oral ivermectin formulations in Corriedale lambs, finding similar systemic exposure across formulations but limited clinical efficacy against several GI nematodes due to widespread resistance, highlighting lack of formulation-dependent bioavai…
DOI: 10.1186/1746-6148-9-27 -
Effective treatment of sarcoptic mange in an alpaca (Vicugna pacos) using fluralaner: a case report
A single-case report showing that a 5 mg/kg oral dose of fluralaner cured sarcoptic mange in a pregnant alpaca (Vicugna pacos) within weeks, with complete clinical resolution, weight restoration, and fiber quality recovery over several months.
DOI: 10.1007/s11259-024-10316-0 -
The Approved Dose of Ivermectin Alone is not the Ideal Dose for the Treatment of COVID‐19
A pharmacokinetic modeling study concludes that the approved oral dose of ivermectin is unlikely to reach inhibitory lung concentrations against SARS-CoV-2, suggesting limited efficacy at standard dosing and proposing exploration of higher dosing, alternative delivery (e.g., inh…
DOI: 10.1002/cpt.1889 -
The Ivomec SR Bolus for Control of <I>Boophilus annulatus</I> (Acari: Ixodidae) on Cattle in South Texas
This study evaluated the efficacy of the Ivomec SR Bolus, a sustained-release ivermectin delivery system, for controlling Boophilus annulatus (cattle ticks) in infested pastures, finding that a single bolus provides partial control while two boluses achieve near-complete tick su…
DOI: 10.1603/0022-0493-94.6.1622 -
High concentrations of membrane-fed ivermectin are required for substantial lethal and sublethal impacts on Aedes aegypti
A laboratory membrane-feeding study on Ae. aegypti evaluated the lethal and sublethal effects of ingested ivermectin across a dose range, finding that very high concentrations are required for substantial mortality and that sublethal impacts on fecundity and egg hatch occur only…
DOI: 10.1186/s13071-020-04512-5